-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual General and Administrative Expense history and growth rate from 2019 to 2022.
- Tarsus Pharmaceuticals, Inc. General and Administrative Expense for the quarter ending September 30, 2024 was $57.9M, a 91% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. annual General and Administrative Expense for 2022 was $44.9M, a 77% increase from 2021.
- Tarsus Pharmaceuticals, Inc. annual General and Administrative Expense for 2021 was $25.4M, a 211% increase from 2020.
- Tarsus Pharmaceuticals, Inc. annual General and Administrative Expense for 2020 was $8.17M, a 619% increase from 2019.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)